Previous studies have indicated miR-769-5p’s oncogenic role in various cancer types; notably, miR-769-5p promoted tumor progression in 62 gastric cancer patients by suppressing YY-1 binding protein expression [24]. This evidence concerns the gene YY1 and neoplasm.